Literature DB >> 16542390

Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype.

D A Stevenson1, D H Viskochil, A F Rope, J C Carey.   

Abstract

Neurofibromatosis-Noonan syndrome (NFNS) has been described as a unique phenotype, combining manifestations of neurofibromatosis type 1 (NF1) and Noonan syndrome, which are separate syndromes. Potential etiologies of NFNS include a discrete syndrome of distinct etiology, co-segregation of two mutated common genes, variable clinical expressivity of NF1, and/or allelic heterogeneity. We present an informative family with an unusual NF1 mutation with variable features of NF1 and Noonan syndrome. We hypothesize that an NF1 mutant allele can lead to diagnostic manifestations of Noonan syndrome, supporting the hypothesis that NF1 allelic heterogeneity causes NFNS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16542390      PMCID: PMC3243644          DOI: 10.1111/j.1399-0004.2006.00576.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  36 in total

Review 1.  Neurofibromatosis-Noonan syndrome.

Authors:  J C Carey
Journal:  Am J Med Genet       Date:  1998-01-23

2.  The Ullrich-Noonan syndrome (Turner phenotype).

Authors:  J J Nora; A H Nora; A K Sinha; R D Spangler; H A Lubs
Journal:  Am J Dis Child       Date:  1974-01

3.  Novel recurrent nonsense mutation causing neurofibromatosis type 1 (NF1) in a family segregating both NF1 and Noonan syndrome.

Authors:  M Bahuau; C Houdayer; B Assouline; C Blanchet-Bardon; M Le Merrer; S Lyonnet; S Giraud; D Récan; H Lakhdar; M Vidaud; D Vidaud
Journal:  Am J Med Genet       Date:  1998-01-23

4.  Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity.

Authors:  Z Q Shi; D H Yu; M Park; M Marshall; G S Feng
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  Regulation of the mitogen-activated protein kinase signaling pathway by SHP2.

Authors:  Jess M Cunnick; Songshu Meng; Yuan Ren; Caroline Desponts; Hong-Gang Wang; Julie Y Djeu; Jie Wu
Journal:  J Biol Chem       Date:  2002-01-04       Impact factor: 5.157

6.  Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia.

Authors:  Marco Tartaglia; Charlotte M Niemeyer; Alessandra Fragale; Xiaoling Song; Jochen Buechner; Andreas Jung; Karel Hählen; Henrik Hasle; Jonathan D Licht; Bruce D Gelb
Journal:  Nat Genet       Date:  2003-06       Impact factor: 38.330

7.  Neurofibromatosis type I gene mutation in a patient with features of LEOPARD syndrome.

Authors:  R Wu; E Legius; W Robberecht; M Dumoulin; J J Cassiman; J P Fryns
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

8.  The genetic aspects of neurofibromatosis.

Authors:  J C Carey; B J Baty; J P Johnson; T Morrison; M Skolnick; J Kivlin
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

9.  Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene.

Authors:  Maria Cristina Digilio; Emanuela Conti; Anna Sarkozy; Rita Mingarelli; Tania Dottorini; Bruno Marino; Antonio Pizzuti; Bruno Dallapiccola
Journal:  Am J Hum Genet       Date:  2002-06-07       Impact factor: 11.025

10.  Noonan syndrome with café-au-lait spots and multiple lentigines syndrome are not linked to the neurofibromatosis type 1 locus.

Authors:  B E Ahlbom; N Dahl; P Zetterqvist; G Annerén
Journal:  Clin Genet       Date:  1995-08       Impact factor: 4.438

View more
  13 in total

1.  SPRED 1 mutations in a neurofibromatosis clinic.

Authors:  Talia M Muram-Zborovski; David A Stevenson; David H Viskochil; David C Dries; Andrew R Wilson
Journal:  J Child Neurol       Date:  2010-02-22       Impact factor: 1.987

2.  NF1 exon 22 analysis of individuals with the clinical diagnosis of neurofibromatosis type 1.

Authors:  Talia M Muram-Zborovski; Cecily P Vaughn; David H Viskochil; Heather Hanson; Rong Mao; David A Stevenson
Journal:  Am J Med Genet A       Date:  2010-08       Impact factor: 2.802

3.  An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation.

Authors:  M Upadhyaya; S M Huson; M Davies; N Thomas; N Chuzhanova; S Giovannini; D G Evans; E Howard; B Kerr; S Griffiths; C Consoli; L Side; D Adams; M Pierpont; R Hachen; A Barnicoat; H Li; P Wallace; J P Van Biervliet; D Stevenson; D Viskochil; D Baralle; E Haan; V Riccardi; P Turnpenny; C Lazaro; L Messiaen
Journal:  Am J Hum Genet       Date:  2006-12-08       Impact factor: 11.025

Review 4.  LZTR1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis.

Authors:  Kirsten M Farncombe; Emily Thain; Carolina Barnett-Tapia; Hamid Sadeghian; Raymond H Kim
Journal:  BMC Med Genomics       Date:  2022-07-15       Impact factor: 3.622

5.  Increased rate of missense/in-frame mutations in individuals with NF1-related pulmonary stenosis: a novel genotype-phenotype correlation.

Authors:  Shay Ben-Shachar; Shlomi Constantini; Hen Hallevi; Emma K Sach; Meena Upadhyaya; Gareth D Evans; Susan M Huson
Journal:  Eur J Hum Genet       Date:  2012-10-10       Impact factor: 4.246

6.  Neurofibromatosis type 1 (NF1) associated with tumor of the corpus callosum.

Authors:  Ignacio Pascual-Castroviejo; Samuel-Ignacio Pascual-Pascual
Journal:  Childs Nerv Syst       Date:  2012-09-22       Impact factor: 1.475

Review 7.  The RASopathies.

Authors:  Katherine A Rauen
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-07-15       Impact factor: 8.929

8.  Juvenile xanthogranuloma in Noonan syndrome.

Authors:  Marwan M Ali; Amy E Gilliam; Beth S Ruben; William E Tidyman; Katherine A Rauen
Journal:  Am J Med Genet A       Date:  2021-05-25       Impact factor: 2.578

Review 9.  Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms.

Authors:  Jody F Longo; Shannon M Weber; Brittany P Turner-Ivey; Steven L Carroll
Journal:  Adv Anat Pathol       Date:  2018-09       Impact factor: 4.571

Review 10.  Leopard syndrome.

Authors:  Anna Sarkozy; Maria Cristina Digilio; Bruno Dallapiccola
Journal:  Orphanet J Rare Dis       Date:  2008-05-27       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.